(1) As used in this section:

Terms Used In Oregon Statutes 689.696

  • Evidence: Information presented in testimony or in documents that is used to persuade the fact finder (judge or jury) to decide the case for one side or the other.
  • Person: means an individual, corporation, partnership, association or other legal entity. See Oregon Statutes 689.005
  • Pharmacist: means an individual licensed by this state to engage in the practice of pharmacy or to engage in the practice of clinical pharmacy. See Oregon Statutes 689.005
  • Pharmacy: means a place that meets the requirements of rules of the board, is licensed and approved by the board where the practice of pharmacy may lawfully occur and includes apothecaries, drug stores, dispensaries, hospital outpatient pharmacies, pharmacy departments and prescription laboratories but does not include a place used by a manufacturer or wholesaler. See Oregon Statutes 689.005

(a) ‘Insulin’ includes various types of insulin analogs and insulin-like medications, regardless of activation period or whether the solution is mixed before or after dispensation.

(b) ‘Insulin-related devices and supplies’:

(A) Includes needles, syringes, cartridge systems, prefilled pen systems, glucose meters and test strips.

(B) Does not include insulin pump devices.

(2)(a) A pharmacist may prescribe and dispense emergency refills of insulin and associated insulin-related devices and supplies to a person who has evidence of a previous prescription from a licensed health care provider.

(b) The insulin prescribed and dispensed under this section must be the lesser of a 30-day supply or the smallest available package.

(c) A person may be prescribed and receive not more than three emergency refills of insulin and associated insulin-related devices and supplies in a calendar year.

(3) A pharmacist who prescribes and dispenses emergency refills of insulin and associated insulin-related devices and supplies under this section shall:

(a) Complete a patient assessment to determine whether the prescription of emergency refills of insulin and associated insulin-related devices and supplies is appropriate;

(b) Document the patient visit and include notations regarding evidence of the patient’s previous prescription from the patient’s licensed health care provider, information relating to the patient’s diabetes management and other relevant information; and

(c) Make a reasonable attempt to inform the person’s primary care provider, and the licensed health care provider who made the previous prescription, of the pharmacist’s prescription for emergency refills of insulin and associated insulin-related devices and supplies.

(4) The State Board of Pharmacy shall adopt rules to carry out this section. [2019 c.95 § 2; 2019 c.95 § 3; 2023 c.93 § 6]